For the first time ever, investment firm RBC Capital released its Small-Cap Growth Idea list, made up of stocks with market caps below …
Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them …
Don’t count all beaten-down stocks out just yet. We mean the names that have seen share prices trend lower as a result of …
Agios Pharmaceuticals Inc (NASDAQ:AGIO) outlined key 2017 milestones in conjunction with its presentation at the 35th Annual J.P.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) announced the appointment of Ian Clark to its board of directors. Most recently, Mr.
Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares were thundering down 19% yesterday after news came to light that the firm has withdrawn its Investigational New …
In a research report published Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), with a …
Agios Pharmaceuticals Inc (NASDAQ:AGIO) announced that it is offering to sell, subject to market and other conditions, up to $150 million of its …
Agios Pharmaceuticals Inc (NASDAQ:AGIO) announced that its collaboration partner Celgene Corporation (NASDAQ:CELG) intends to file for an NDA for its AML-treating drug AG-221 …
Agios Pharmaceuticals Inc (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, announced that Andrew Hirsch is joining the …